NKT Therapeutics
ID: 5291183A biotechnology company developing treat ments for sickle cell disease, cancer, asthma autoimmune and inflammatory diseases
2
Funding Rounds
$12.0m
Money raised
Recent Funding Rounds
Overview
A biotechnology company developing treat ments for sickle cell disease, cancer, asthma autoimmune and inflammatory diseases
- Website:
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company NKT Therapeutics has raised a total of $12m in funding over 2 rounds.
Key Insights:
- NKT Therapeutics funding round, August 2010: $4m
- NKT Therapeutics Series A round: $8m
Industries
NKT Therapeutics is active in the following industries: